Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: a population-based study (scientific article published on 11 October 2013)

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

Q33391830

Cardiovascular disease is the leading cause of death among endometrial cancer patients

Q34268521

Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease.

Q34990687

Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials

Q35750598

Reporting of cause-specific treatment effects in cancer clinical trials with competing risks: a systematic review

Q38016057

Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis

Q38042049

Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma

Q40355966

The Analysis of Failure Times in the Presence of Competing Risks

Q41031423

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis

Q44140053

Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysis.

Q53024816

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Q53204711

Systematic lymphadenectomy for survival in patients with endometrial cancer: a meta-analysis.

Q53385086

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

Q63199185

The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer

Q84272325

Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma

Q84272366

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

endometrial cancer

Q944777

lymphadenectomy

Q1809305

P304

page(s)

1656-1666

P577

publication date

2013-10-11

P1433

published in

Journal of the National Cancer Institute

Q400279

P1476

title

Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: a population-based study

P478

volume

105

Reverse relations

cites work (P2860)

Q38793293	Does a groin node dissection in vulvar cancer affect groin recurrence and overall survival?: Results from a population-based cohort study
Q51419310	LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis.
Q40897111	Long-term life expectancy for children with ependymoma and medulloblastoma
Q36822417	Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).
Q39205677	Patterns of adjuvant radiation usage and survival outcomes for stage I endometrial carcinoma in a large hospital-based cohort
Q89022300	Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer
Q36068850	Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review.
Q41405578	Vaginal cuff brachytherapy in endometrial cancer - a technically easy treatment?